ARRY Related Earnings News
-
Array Biopharma, Inc. (ARRY) Misses Q3 EPS by 4c; to Commence MEK162 Phase 3
-
Array Biopharma, Inc. (ARRY) Tops Q2 EPS by 4c
-
Array Biopharma, Inc. (ARRY) Tops Q1 EPS by 2c
-
Jefferies Maintains a 'Buy' on Array BioPharma (ARRY); Narrowing Loss; Phase 2 Data Driving Further Upside
-
Array Biopharma, Inc. (ARRY) Posts Q4 Loss of 9c/Share, Narrower than Views
-
Array Biopharma, Inc. (ARRY) Posts Narrower than Expected Q1 Loss
-
Array Biopharma, Inc. (ARRY) Posts Q2 Loss of $0.06, Sales Top Expectations
-
Array Biopharma, Inc. (ARRY) Reports Q1 EPS Loss of $0.06, Sales Beat Expectations
-
Array Biopharma, Inc. (ARRY) Reports Q2 Loss of 17c/Share
-
Array BioPharma (ARRY) Posts Mixed Q3 Results
-
Array BioPharma, Inc. (ARRY) Tops Q2 EPS by 5c
-
Array BioPharma (ARRY) Sees FY11 Milestone Payments of $20-$30M
-
Array Biopharma (ARRY) Tops Q3 EPS by 8c
-
Array Biopharma (ARRY) Reports Smaller-Than-Expected Q2 Loss
-
Array Biopharma (ARRY) Reports Smaller-Than-Expected Q3 Loss; CEO Comments on Potential Milestone Payments From Partners
-
Array BioPharma (ARRY) Tops Q2 Views
-
Array BioPharma (ARRY) Reports Q1 Loss of $0.52, Beats by 3c
-
Array BioPharma (ARRY) Tops Q4 EPS by 1c on Light Revenues
-
Array BioPharma (ARRY) Tops Q4 EPS by 1c
-
Array BioPharma (ARRY) Misses Q1 EPS by 3c; Revs Light
-
Array BioPharma (ARRY) Reports a Q2 Loss; Comments on Outlook
-
Array BioPharma (ARRY) Reports Q2 Loss of $0.79
-
Array BioPharma (ARRY) Tops Q3 EPS by 4c
-
Array BioPharma (ARRY) Reports Wider Q4 Loss
-
Array BioPharma (ARRY) Tops Q3 EPS by 1c; Receives $80 Million Funding Commitment
-
Array BioPharma Inc. (ARRY) Reports A Q4 Loss of 43 Cents
-
Array BioPharma Inc. (ARRY) Reports Q3 Loss
-
Array BioPharma (ARRY) Misses Q2 EPS by 3c
-
Array BioPharma Inc. (ARRY) Reports a Q3 Loss of $0.24
Back to ARRY Stock Lookup
